The DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index; 11 of the 26 sources its claims cite were checked for support.
Autism spectrum disorder in ICD-11—a critical reflection of its possible impact on clinical practice and research
Open accessAbstract
This perspective article compares and contrasts the conceptualization of Autism Spectrum Disorder (ASD) in ICD-11 and DSM-5. By guiding the user through the ICD-11 text, it is argued that, in contrast to DSM-5, ICD-11 allows a high variety in symptom combinations, which results in an operationalization of ASD that is in favor of an extreme diverse picture, yet possibly at the expense of precision, including unforeseeable effects on clinical practice, care, and research. The clinical utility is questionable as this conceptualization can hardly be differentiated from other mental disorders and autism-like traits. It moves away from an observable, behavioral, and neurodevelopmental disorder to a disorder of inner experience that can hardly be measured objectively. It contains many vague and subjective concepts that lead to non-falsifiable diagnoses. This bears a large danger of false positive diagnoses, of further increased prevalence rates, limitations of access to ASD-specific services and of increasing the non-specificity of treatments. For research, the hypothesis is that the specificity of ASD will be reduced and this will additional increase the already high heterogeneity with the effect that replication of studies will be hampered. This could limit our understanding of etiology and biological pathways of ASD and bears the risk that precision medicine, i.e., a targeted approach for individual treatment strategies based on precise diagnostic markers, is more far from becoming reality. Thus, a more precise, quantitative description and more objective measurement of symptoms are suggested that define the clinical ASD phenotype. Identification of core ASD subtypes/endophenotypes and a precise description of symptoms is the necessary next step to advance diagnostic classification systems. Therefore, employing a more finely grained, objective, clinical symptom characterization which is more relatable to neurobehavioral concepts is of central significance.
Overview
CoChat Summary
TL;DR
This perspective argues that ICD-11’s ASD conceptualization is broader and less prescriptive than DSM-5, allowing many symptom combinations and vague/subjective concepts, which may reduce specificity and increase false positives. It warns this could worsen heterogeneity, hamper replication and precision medicine, and limit access to ASD-specific services.
Key findings
- ICD-11 lists 19 social communication/interaction manifestations and 16 restricted/repetitive features, yielding 304 possible combinations, with no mandatory social-communication criteria; the paper argues this broad operationalization risks arbitrary symptom presentations and false positive diagnoses.
- The paper says ICD-11 moves away from an observable, behavioral, neurodevelopmental disorder toward a disorder of inner experience/identity, emphasizing compensation and symptoms “only apparent in retrospect”; compensation lacks an agreed definition and its empirical evidence is questionable, leading to non-falsifiable diagnoses.
- Clinically, differentiation from other mental disorders and autism-like traits becomes difficult; around 80% of individuals with ASD have at least one comorbid disorder, and false positives may limit access for true positives and delay disorder-specific care.
- For research, high heterogeneity already decreases effect sizes up to 80% in cognitive, EEG, and neuroanatomical studies and hampers replication; ICD-11 may further increase heterogeneity, limiting understanding of etiology/biological pathways and precision medicine.
Methods
- Perspective/critical reflection article comparing ICD-11 and DSM-5 conceptualizations of ASD by guiding the reader through the ICD-11 text; all ICD-11 citations are from reference [11].
- No empirical sample or primary data; the analysis is conceptual/textual, evaluating diagnostic requirements, specifiers, additional features, boundary with normality, differential diagnosis, and implications for clinical practice and research.
- The author proposes more precise, quantitative, objective symptom characterization and identification of core ASD subtypes/endophenotypes.
Limitations
- The paper states that the discussion about heterogeneity and prototypes is presented elsewhere and is “not the subject of this perspective article”; no formal limitations section is provided.
- Evident from the text: it is a single-author perspective, not a systematic review or empirical test, so conclusions about ICD-11’s impact are hypotheses/projections rather than measured outcomes.
- Evident from the text: it relies on textual analysis of ICD-11 and selected literature, with no new data to quantify false positives, prevalence changes, or service-access effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
6 Valid · 0 Not valid · 9 Not checked · 23 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“there is a lack of replication from genetic, brain imaging, EEG, and metabolic studies (e.g., [8]) (for review see: [9])”
- Also stated in: § Increased heterogeneity · plain
“there is a lack of replication from genetic, brain imaging, EEG, and metabolic studies (e.g., [8]) (for review see: [9]).”
§ Autism spectrum disorder in ICD-11—a critical reflection of its possible impact on clinical practice and research > Introduction > Increased heterogeneity
What the sources say
- Supportedcites [8] Torrico B, Chiocchetti AG, Bacchelli E, Trabetti E, Hervás A, Franke B, et al. Lack of replication of previous autism spectrum disorder GWAS hits in European populations. Autism Res. 2017;10:202–11. source
The Discussion (p. 7) says the study did not replicate three previous ASD GWAS signals in its European samples or meta-analysis. The citing sentence presents this paper as an example, while assigning the broader review to a separate citation; this source supports the genetic-studies example. (LLM, conf=0.91)
- Partly supportedcites [9] Lord C, Brugha TS, Charman T, Cusack J, Dumas G, Frazier T, et al. Autism spectrum disorder. Nat Rev Dis Prim. 2020;6:5. sourceExperimental — accuracy not yet measured
The Neurobiology section reports replication problems in ASD MRI studies and says EEG/MEG findings need replication across research centres. But the Genetics section describes more than 100 confidently associated genes and genomic regions and says some genetic associations are strong and reliable; the passages do not establish a lack of replication in metabolic studies. The claim therefore extends the paper's replication concern beyond the fields it supports. (LLM, conf=0.87)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Increased heterogeneity · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Additionally, there is some evidence that there is low agreement between diagnoses based on anamnestic interviews (ADI-R) and those based on behavioral observations, particularly for older and atypical cases, and for better performance of the behavioral observation ([22, 30, 34–40].”
§ Autism spectrum disorder in ICD-11—a critical reflection of its possible impact on clinical practice and research > ICD-11: Boundary with normality (threshold) and developmental presentation
What the sources say
- Not checked — no full text of the sourcecites [22] Havdahl KA, Bishop SL, Suren P, Oyen AS, Lord C, Pickles A, et al. The influence of parental concern on the utility of autism diagnostic instruments. Autism Res. 2017;10:1672–86. source
- Supportedcites [30] Kamp-Becker I, Tauscher J, Wolff N, Küpper C, Poustka L, Roepke S, et al. Is the combination of ADOS and ADI-R necessary to classify ASD? Rethinking the “Gold Standard” in diagnosing ASD. Front Psychiatry. 2021;12:727308. source
The Introduction (page not provided) explicitly reports low agreement between ADI-R-based and ADOS-based diagnoses, particularly for older and atypical cases. It identifies ADOS as direct behavioral observation and ADI-R as an anamnestic interview. (LLM, conf=0.95)
- Not checked — no full text of the sourcecites [34] de Bildt A, Sytema S, Ketelaars C, Kraijer D, Mulder E, Volkmar F, et al. Interrelationship between Autism Diagnostic Observation Schedule-Generic (ADOS-G), Autism Diagnostic Interview-Revised (ADI-R), and the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) classification in children and adolescents with mental retardation. J Autism Dev Disord. 2004;34:129–37. source
- Partly supportedcites [35] Bishop DVM, Norbury CF. Exploring the borderlands of autistic disorder and specific language impairment: a study using standardised diagnostic instruments. J Child Psychol Psychiatry. 2002;43:917–29. sourceExperimental — accuracy not yet measured
The ‘Relationship between ADI-R, ADOS and previous diagnoses’ section reports poor agreement between ADI-R and ADOS-G diagnoses. The ‘Clinical implications: Assessment’ section suggests that the unusual, diagnostically challenging sample may partly explain it, and ‘Clinical implications: Diagnostic issues’ discusses children whose presentation changed with age. The paper does not establish that agreement is particularly low in older or atypical cases relative to other cases. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [36] Chawarska K, Paul R, Klin A, Hannigen S, Dichtel LE, Volkmar F. Parental recognition of developmental problems in toddlers with autism spectrum disorders. J Autism Dev Disord. 2007;37:62–72. source
- Not checked — no full text of the sourcecites [37] Le Couteur A, Haden G, Hammal D, McConachie H. Diagnosing autism spectrum disorders in pre-school children using two standardised assessment instruments: the ADI-R and the ADOS. J Autism Dev Disord. 2008;38:362–72. source
- Not checked — no full text of the sourcecites [38] Lebersfeld JB, Swanson M, Clesi CD, O’Kelley SE. Systematic review and meta-analysis of the clinical utility of the ADOS-2 and the ADI-R in diagnosing autism spectrum disorders in children. J Autism Dev Disord. 2021;51:4101–14. source
- Partly supportedcites [39] Oosterling I, Roos S, de Bildt A, Rommelse N, de Jonge M, Visser J, et al. Improved diagnostic validity of the ADOS revised algorithms: a replication study in an independent sample. J Autism Dev Disord. 2010;40:689–703. sourceExperimental — accuracy not yet measured
The Additional Analyses to Explain ADOS Outcomes section reports poor agreement between ADOS and ADI-R classifications (κ < 0.40). It does not establish that agreement was particularly low for older or atypical cases; its comparison of test performance varies by developmental group rather than consistently favoring behavioral observation. Page numbers are unavailable in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [40] Papanikolaou K, Paliokosta E, Houliaras G, Vgenopoulou S, Giouroukou E, Pehlivanidis A, et al. Using the Autism Diagnostic Interview-Revised and the Autism Diagnostic Observation Schedule-Generic for the diagnosis of autism spectrum disorders in a Greek sample with a wide range of intellectual abilities. J Autism Dev Disord. 2009;39:414–20. source
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“decreasing of effect sizes up to 80% in cognitive, EEG, and neuroanatomical studies [7]”
§ Autism spectrum disorder in ICD-11—a critical reflection of its possible impact on clinical practice and research > Introduction > Increased heterogeneity
What the sources say
- Partly supportedcites [7] Rødgaard E-M, Jensen K, Vergnes J-N, Soulières I, Mottron L. Temporal changes in effect sizes of studies comparing individuals with and without autism: a meta-analysis. JAMA Psychiatry. 2019;76:1124–32. sourceExperimental — accuracy not yet measured
The Discussion reports that effect sizes in autism studies fell by 45% to more than 80% from 2000 to 2015 among constructs with significant temporal decreases. The Results include cognitive measures, P3b amplitude, and brain size. The Discussion proposes population heterogeneity as a possible explanation, but does not establish that high heterogeneity caused the decreases. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
In the paper
“Interestingly, features that are mostly associated with low-functioning or non-verbal ASD at younger age (such as flipping objects, preoccupation with unusual objects, excessive smelling or touching of objects, echolalia, visual fascination with lights or movement etc.) are not named in ICD-11.”
§ Autism spectrum disorder in ICD-11—a critical reflection of its possible impact on clinical practice and research > ICD-11: Description and diagnostic requirements for ASD
What the sources say
- Not matchedcites [11] World Health Organization. ICD-11 for mortality and morbidity statistics: 6A02 autism spectrum disorder; 2022.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“ICD-11 allows a high variety in symptom combinations, which results in an operationalization of ASD that is in favor of an extreme diverse picture”
- Also stated in: § Main critique on the ICD-11 conceptualization of ASD · plain
“ICD-11 defines ASD via a great amount of possible, but not mandatory features, some of which might not be detectable via direct observation.”
- Also stated in: § ICD-11: Description and diagnostic requirements for ASD · plain
“Altogether, 304 (19 × 16) combinations of manifestations are possible.”
§ Autism spectrum disorder in ICD-11—a critical reflection of its possible impact on clinical practice and research > Abstract
What the sources say
- Not matchedcites [11] World Health Organization. ICD-11 for mortality and morbidity statistics: 6A02 autism spectrum disorder; 2022.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Main critique on the ICD-11 conceptualization of ASD · plain
14 more claims
Create a free account to see all 38 claims and every source verdict.
- It may state two separate claims as one. 9
- Probably not a substantial claim. 14
- The quote only partly states this claim. 1
Citations
Cites
Kotov, R., Krueger, R. F., Watson, D., Achenbach, T. M., Althoff, R. R., Bagby, R. M., Brown, T. A., Carpenter, W. T., Caspi, A., Clark, L. A., et al. (2017) · Journal of Abnormal Psychology · doi:10.1037/abn0000258 · Cited by 3,335
Toward the future of psychiatric diagnosis: the seven pillars of RDoC
Cuthbert, B. N., & Insel, T. R. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-126 · Cited by 3,053
Lord, C., Brugha, T. S., Charman, T., Cusack, J., Dumas, G., Frazier, T., Jones, E. J. H., Jones, R. M., Pickles, A., State, M. W., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0138-4 · Cited by 1,859 · cited 1×
“Furthermore, it might also affect research, e.g., decreasing of effect sizes up to 80% in cognitive, EEG, and neuroanatomical studies [7] and by now, there is a lack of replication from genetic, brain imaging, EEG, and metabolic studies (e.g., [8]) (for review see: [9]).”
BackgroundAnnual Research Review: Shifting from ‘normal science’ to neurodiversity in autism science
Pellicano, E., & den Houting, J. (2022) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13534 · Cited by 744 · cited 1×
“In this conceptualization, ASD is one form of variation within a diversity of minds and the dif fi culties are not understood as a de fi cit or disorder, but rather as a poor fi t between individual ’ s characteristics and demands by the environment [2], so that search for a cure is being rejected.”
BackgroundHus, V., & Lord, C. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2080-3 · Cited by 547
Big data approaches to decomposing heterogeneity across the autism spectrum
Lombardo, M. V., Lai, M.-C., & Baron-Cohen, S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0321-0 · Cited by 537 · cited 2×
“Alongside the changes in classi fi cation systems, by now heterogeneity has already increased with regard to the expression and severity of the core and associated symptoms of ASD [4 – 6].”
BackgroundHossain, M. M., Khan, N., Sultana, A., Ma, P., McKyer, E. L. J., Ahmed, H. U., & Purohit, N. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112922 · Cited by 504
Bishop, D. V. M., & Norbury, C. F. (2002) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00114 · Cited by 474
Livingston, L. A., & Happé, F. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.06.005 · Cited by 414
Autism spectrum heterogeneity: fact or artifact?
Mottron, L., & Bzdok, D. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0748-y · Cited by 332
Cited by
Latest clinical frontiers related to autism diagnostic strategies
Cortese, S., Bellato, A., Gabellone, A., Marzulli, L., Matera, E., Parlatini, V., Petruzzelli, M. G., Persico, A. M., Delorme, R., Fusar‐Poli, P., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101916 · Cited by 48
Tomaszek, N., Urbaniak, A. D., Bałdyga, D., Chwesiuk, K., Modzelewski, S., & Waszkiewicz, N. (2025) · Nutrients · doi:10.3390/nu17030486 · Cited by 30
Herrero-Martín, J., Fonseca, D., Caro-Via, S., & Canaleta, X. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1455627 · Cited by 19
Explainable Federated Learning for Enhanced Privacy in Autism Prediction Using Deep Learning
AlShammari, N. K., Alhusaini, A. A., Pasha, A., Ahamed, S. S., Gadekallu, T. R., Abdullah-Al-Wadud, M., Ramadan, R. A., & Alrashidi, M. (2024) · Journal of Disability Research · doi:10.57197/jdr-2024-0081 · Cited by 16
Almadhor, A. S., Alasiry, A., Alsubai, S., Hejaili, A. A., Kovac, U., & Abbas, S. (2025) · Complex & Intelligent Systems · doi:10.1007/s40747-025-01790-3 · Cited by 14
Metadata
- Authors
- Kamp-Becker, I.
- Venue
- Molecular Psychiatry
- Published
- 2024-01-25
- Volume
- 29
- Issue
- 3
- Pages
- 633-638
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC11153155
- OpenAlex
- W4391225641
- Cited by
- 63
- References
- 71
- Citations by year
- 2026: 22 · 2025: 28 · 2024: 13
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Molecular Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PUBLISSO (German National Library of Medicine) (submittedVersion, other-oa)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- autism spectrum disorder, ICD-11, DSM-5, diagnostic classification, diagnostic criteria, symptom heterogeneity, false-positive diagnosis, autistic traits, autism prevalence, replication, precision medicine, endophenotypes, clinical practice
- MeSH terms
- Autism Spectrum Disorder, Child, Humans, International Classification of Diseases, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autism spectrum disorder in ICD-11—a critical reflection of its possible impact on clinical practice and research. https://app.cochat.ai/papers/10.1038/s41380-023-02354-y
- The paper
- Kamp-Becker, I. (2024). Autism spectrum disorder in ICD-11—a critical reflection of its possible impact on clinical practice and research. Molecular Psychiatry. https://doi.org/10.1038/s41380-023-02354-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.